5 Best Dialysis and Kidney Disease Stocks to Buy

Page 1 of 5

In this piece, we will take a look at the 5 best dialysis and kidney disease stocks to buy. To see more such companies, go directly to 10 Best Dialysis and Kidney Disease Stocks to Buy.

5. Boston Scientific Corporation (NYSE:BSX)

Number of Hedge Fund Holders In Q2 2023: 69

Market Capitalization: $73.9 Billion

Founded in 1979 and headquartered in Massachusetts, Boston Scientific Corporation (NYSE:BSX) ranks 5th in our list of the best dialysis and kidney disease stocks to buy. The company strives to provide innovative and differentiated dialysis solutions to its customers. Boston Scientific Corporation (NYSE:BSX) offers treatment for Hemodialysis end-stage renal patients. The firm also provides numerous treatment plans for kidney stones.

As of Q2 2023, 69 out of the 910 hedge funds part of Insider Monkey’s database had held a stake in the company. Boston Scientific Corporation (NYSE:BSX)’s largest hedge fund shareholder is Ken Griffin’s Citadel Investment Group due to its $836 million stake.

Page 1 of 5